This review critically integrates current evidence on hepatic lipid metabolic reprogramming, lipid-mediated signaling, organelle dysfunction, fibrosis, and molecular heterogeneity in MASLD to support molecular endotyping, mechanism-based therapeutic strategies, and precision hepatology in patients with metabolic dysfun...
Tatjana Ábel, Éva Csobod Csajbókné· International Journal of Mol...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.